Antibody-mediated Rejection

Also known as: Transplant rejection / Transplant rejections / Graft Rejection

DrugDrug NameDrug Description
DB00098Antithymocyte immunoglobulin (rabbit)Rabbit anti-thymocyte globulin. Thymoglobulin is a polyclonal antibody that suppresses certain types of immune cells responsible for acute organ rejection in transplant patients. Thymoglobulin is a mixture of antibodies intended to bind to various cell surface antigens. The most common mode of action of Thymoglobulin is via selective depletion of T-cells.
DrugDrug NamePhaseStatusCount
DB12849Clazakizumab1 / 2Active Not Recruiting1
DB12849Clazakizumab1 / 2Recruiting1
DB00098Antithymocyte immunoglobulin (rabbit)2Not Yet Recruiting1
DB06681Belatacept2Not Yet Recruiting1
DB06681Belatacept2Withdrawn1
DB00188Bortezomib2Completed1
DB08889Carfilzomib2Withdrawn1
DB12849Clazakizumab2Recruiting1
DB01257Eculizumab2Terminated1
DB00028Immune Globulin Human2Terminated1
DB00959Methylprednisolone2Not Yet Recruiting1
DB00688Mycophenolate mofetil2Not Yet Recruiting1
DB01024Mycophenolic acid2Not Yet Recruiting1
DB00635Prednisone2Not Yet Recruiting1
DB09153Sodium chloride2Recruiting1
DB00864Tacrolimus2Not Yet Recruiting1
DB12849Clazakizumab3Recruiting1
DB05341Human C1-esterase inhibitor3Recruiting1
DB01257Eculizumab4Enrolling by Invitation1
DB00188BortezomibNot AvailableRecruiting1